Conversely, gain-of-function mutations in p53 have been shown to repress the transcription of key autophagy genes such as BECN1, DRAM1, and ATG12 while concurrently activating the mTOR pathway, thereby inhibiting autophagy and facilitating tumor cell survival and proliferation [152]. The gene discussed is TP53; the disease is neoplasm.